CONCERT PHARMACEUTICALS INC(NASDAQ:CNCE) stock News

CNCE Latest News, Press Relases and Analysis

All

Press Releases

3 years ago - By: Seeking Alpha

Concert retains breakthrough tag for hair loss therapy despite rival entry (NASDAQ:CNCE)

3 years ago - By: Concert Pharmaceuticals, Inc.

Concert Pharmaceuticals Maintains Deuruxolitinib Breakthrough Therapy Designation from FDA for the Treatment of Alopecia Areata

3 years ago - By: Halper Sadeh LLC

CNCE Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Concert Pharmaceuticals, Inc. Is Fair to Shareholders

3 years ago - By: Benzinga - Mentions: SRDX TNXP BLCM BYSI ...

12 Health Care Stocks Moving In Thursday's Intraday Session

3 years ago - By: Benzinga

India-Based Sun Pharma Scoops Up Concert Pharmaceuticals For $576M Plus Milestones

3 years ago - By: Sun Pharmaceutical Industries Ltd.

Sun Pharma entend acquérir Concert Pharmaceuticals pour faire progresser le traitement potentiel de l'alopécie areata

3 years ago - By: Sun Pharmaceutical Industries Ltd.

Sun Pharma adquire Concert Pharmaceuticals, avançando no tratamento potencial para a Alopecia Areata

3 years ago - By: Sun Pharmaceutical Industries Ltd.

Sun Pharma adquiere Concert Pharmaceuticals para avanzar en el tratamiento de la alopecia areata

3 years ago - By: Sun Pharmaceutical Industries Ltd.

Sun Pharma erwirbt Concert Pharmaceuticals und treibt damit die Behandlung von Alopecia areata voran

3 years ago - By: The Motley Fool

Why Concert Pharmaceuticals Stock Rocketed Higher This Week

3 years ago - By: Kahn Swick & Foti, LLC

CONCERT PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Concert Pharmaceuticals, Inc. - CNCE

3 years ago - By: Weiss Law

SHAREHOLDER ALERT: Weiss Law Investigates Concert Pharmaceuticals, Inc.

3 years ago - By: Seeking Alpha - Mentions: RIVN SRDX EDU

Hot Stocks: CNCE takeover deal; SRDX plunges; EDU reaches 52-week high; RIVN sets new low

3 years ago - By: Ademi LLP

Shareholder Alert: Ademi LLP investigates whether Concert Pharmaceuticals, Inc. has obtained a Fair Price in its transaction with Sun Pharma

3 years ago - By: Halper Sadeh LLC

CNCE Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Concert Pharmaceuticals, Inc. Is Fair to Shareholders

3 years ago - By: Sun Pharmaceutical Industries Ltd.

Sun Pharma to Acquire Concert Pharmaceuticals, Advancing the Potential Treatment of Alopecia Areata

3 years ago - By: Concert Pharmaceuticals

Sun Pharma to Acquire Concert Pharmaceuticals, Advancing the Potential Treatment of Alopecia Areata

3 years ago - By: Concert Pharmaceuticals, Inc.

Concert Pharmaceuticals Announces Presentation of Deuruxolitinib THRIVE-AA1 Phase 3 Study Results in Alopecia Areata During World Congress for Hair Research

3 years ago - By: Concert Pharmaceuticals

CONCERT PHARMACEUTICALS INC (CNCE) Stock News

CNCE Latest News, Press Relases and Analysis

Concert retains breakthrough tag for hair loss therapy despite rival entry (NASDAQ:CNCE)

Concert Pharmaceuticals Maintains Deuruxolitinib Breakthrough Therapy Designation from FDA for the Treatment of Alopecia Areata

CNCE Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Concert Pharmaceuticals, Inc. Is Fair to Shareholders

12 Health Care Stocks Moving In Thursday's Intraday Session

India-Based Sun Pharma Scoops Up Concert Pharmaceuticals For $576M Plus Milestones

Sun Pharma entend acquérir Concert Pharmaceuticals pour faire progresser le traitement potentiel de l'alopécie areata

Sun Pharma adquire Concert Pharmaceuticals, avançando no tratamento potencial para a Alopecia Areata

Sun Pharma adquiere Concert Pharmaceuticals para avanzar en el tratamiento de la alopecia areata

Sun Pharma erwirbt Concert Pharmaceuticals und treibt damit die Behandlung von Alopecia areata voran

Why Concert Pharmaceuticals Stock Rocketed Higher This Week

CONCERT PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Concert Pharmaceuticals, Inc. - CNCE

SHAREHOLDER ALERT: Weiss Law Investigates Concert Pharmaceuticals, Inc.

Hot Stocks: CNCE takeover deal; SRDX plunges; EDU reaches 52-week high; RIVN sets new low

Shareholder Alert: Ademi LLP investigates whether Concert Pharmaceuticals, Inc. has obtained a Fair Price in its transaction with Sun Pharma

CNCE Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Concert Pharmaceuticals, Inc. Is Fair to Shareholders

Sun Pharma to Acquire Concert Pharmaceuticals, Advancing the Potential Treatment of Alopecia Areata

Sun Pharma to Acquire Concert Pharmaceuticals, Advancing the Potential Treatment of Alopecia Areata

Concert Pharmaceuticals Announces Presentation of Deuruxolitinib THRIVE-AA1 Phase 3 Study Results in Alopecia Areata During World Congress for Hair Research

Concert Pharmaceuticals to Participate in Fireside Chat at the Jefferies London Healthcare Conference